Issued Patents All Time
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11851652 | Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated editing of HBB | Matthew H. Porteus, Ayal Hendel, Joe Clark, Daniel E. Ryan, Douglas J. Dellinger +2 more | 2023-12-26 |
| 11773409 | CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors | Matthew H. Porteus, Sriram Vaidyanathan | 2023-10-03 |
| 11634732 | Pharmaceutical compositions comprising gene-corrected primary cells | Daniel P. Dever, Ayal Hendel, Waracharee Srifa, Matthew H. Porteus | 2023-04-25 |
| 11535846 | Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation | Matthew H. Porteus, Ayal Hendel, Joe Clark, Daniel E. Ryan, Douglas J. Dellinger +2 more | 2022-12-27 |
| 11492646 | Nuclease-mediated genome editing of primary cells | Daniel P. Dever, Ayal Hendel, Waracharee Srifa, Matthew H. Porteus | 2022-11-08 |
| 11306309 | Chemically modified guide RNAs for CRISPR/CAS-mediated gene regulation | Matthew H. Porteus, Ayal Hendel, Joe Clark, Daniel E. Ryan, Douglas J. Dellinger +2 more | 2022-04-19 |
| 11193141 | Nuclease-mediated genome editing of primary cells and enrichment thereof | Daniel P. Dever, Ayal Hendel, Waracharee Srifa, Matthew H. Porteus | 2021-12-07 |